Providence Cancer Institute Clackamas Clinic
Clackamas, Oregon, United States
Cancer treatment center in Southgate CPO, Oregon
9280 SE Sunnybrook Blvd Suite 200, Clackamas, OR 97015
About Providence Cancer Institute Clackamas Clinic
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
91
Alliance for Clinical Trials in Oncology
32
SWOG Cancer Research Network
31
ECOG-ACRIN Cancer Research Group
16
NRG Oncology
5
GOG Foundation
3
Gynecologic Oncology Group
3
Pfizer
3
Children's Oncology Group
2
Wake Forest University Health Sciences
2
Providence Health & Services
1
Clinical Trials at Providence Cancer Institute Clackamas Clinic
During the past decade, Providence Cancer Institute Clackamas Clinic conducted 141 clinical trials. In the 10-year time frame, 141 clinical trials started and 53 clinical trials were completed, i.e. on
average, 37.6% percent of trials that started reached the finish line to date. In the past 5 years, 46 clinical trials started and 43 clinical trials were completed. i.e. 93.5%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
2007-10-12
2024-12-01
Active, not recruiting
701
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
2007-12-06
Active, not recruiting
1,052
Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
2008-03-01
Active, not recruiting
731
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
2012-06-18
Unknown status
1,070
Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
2010-02-08
2022-11-02
Active, not recruiting
63
Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery
2010-04-12
Active, not recruiting
341
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
2010-06-01
Active, not recruiting
2,527
Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
2011-01-24
2027-07-20
Active, not recruiting
226
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Providence Cancer Institute Clackamas Clinic" #1 sponsor was "National Cancer Institute (NCI)" with 91 trials, followed by "Alliance for Clinical Trials in Oncology" with 32 trials
sponsored, "SWOG Cancer Research Network" with 31 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 16 trials sponsored and "NRG Oncology"
with 16 trials sponsored. Other sponsors include 10 different institutions and
companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Providence Cancer Institute Clackamas Clinic"
#1 collaborator was "National Cancer Institute (NCI)" with 94 trials as a collaborator, "NRG Oncology" with 17 trials as a collaborator, "Canadian Cancer Trials Group" with 9 trials as a collaborator, "Genentech, Inc." with 3 trials as a collaborator and "Astellas Pharma Inc" with 2 trials as a collaborator. Other collaborators include 19 different institutions and companies that were
collaborators in the rest 27 trials.
Clinical Trials Conditions at Providence Cancer Institute Clackamas Clinic
According to Clinical.Site data, the most researched conditions in "Providence Cancer Institute Clackamas Clinic" are
"Invasive Breast Carcinoma" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Recurrent Breast Carcinoma" (6 trials) and "Recurrent Ovarian Carcinoma" (6 trials). Many other conditions were trialed in "Providence Cancer Institute Clackamas Clinic" in a lesser frequency.
Clinical Trials Intervention Types at Providence Cancer Institute Clackamas Clinic
Most popular intervention types in "Providence Cancer Institute Clackamas Clinic" are "Drug" (153 trials), "Other" (110 trials), "Biological" (89 trials), "Procedure" (62 trials) and "Radiation" (23 trials). Other intervention types were less common.
The name of intervention was led by "Quality-of-Life Assessment" (51 trials), "Laboratory Biomarker Analysis" (46 trials), "Computed Tomography" (39 trials), "Questionnaire Administration" (36 trials) and "Biospecimen Collection" (35 trials). Other intervention names were less common.
Clinical Trials Genders at Providence Cancer Institute Clackamas Clinic
The vast majority of trials in "Providence Cancer Institute Clackamas Clinic" are
159 trials for "All" genders, 28 trials for "Female" genders and 3 trials for "Male" genders.
Clinical Trials Status at Providence Cancer Institute Clackamas Clinic
Currently, there are NaN active trials in "Providence Cancer Institute Clackamas Clinic".
undefined are not yet recruiting,
68 are recruiting,
90 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 19 completed trials in Providence Cancer Institute Clackamas Clinic,
7 suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Providence Cancer Institute Clackamas Clinic, 7 "Phase 1"
clinical trials were conducted, 100 "Phase 2" clinical
trials and 97 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 5 trials that are defined as “Not Applicable".